Langworth-Green, C;
Patel, S;
Jaunmuktane, Z;
Jabbari, E;
Morris, H;
Thom, M;
Lees, A;
... Duff, K; + view all
(2023)
Chronic effects of inflammation on tauopathies.
The Lancet Neurology
, 22
(5)
pp. 430-442.
10.1016/S1474-4422(23)00038-8.
Preview |
Text
Morris_Revised Personal View.pdf Download (827kB) | Preview |
Abstract
Tauopathies are a heterogeneous group of neurodegenerative disorders that are characterised by the aggregation of the microtubule-associated protein tau into filamentous inclusions within neurons and glia. Alzheimer's disease is the most prevalent tauopathy. Despite years of intense research efforts, developing disease-modifying interventions for these disorders has been very challenging. The detrimental role that chronic inflammation plays in the pathogenesis of Alzheimer's disease is increasingly recognised; however, it is largely ascribed to the accumulation of amyloid β, leaving the effect of chronic inflammation on tau pathology and neurofibrillary tangle-related pathways greatly overlooked. Tau pathology can independently arise secondary to a range of triggers that are each associated with inflammatory processes, including infection, repetitive mild traumatic brain injury, seizure activity, and autoimmune disease. A greater understanding of the chronic effects of inflammation on the development and progression of tauopathies could help forge a path for the establishment of effective immunomodulatory disease-modifying interventions for clinical use.
Archive Staff Only
 |
View Item |
